Baden-Württemberg is Germany’s largest pharma location. In addition to industry giants such as Roche, GlaxoSmithKline and Boehringer Ingelheim, Baden-Württemberg is home to a large number of small- and medium-sized pharmaceutical companies and biotech companies with pharmaceutical R&D. According to the Baden-Württemberg Statistics Office, one in four employees in the pharmaceutical industry work in Baden-Württemberg.
The pharmaceutical industry continues to be a recession-proof employer and is very loyal to Baden-Württemberg. According to BIOPRO 126 pharmaceutical companies are located in Baden-Württemberg. Of them, 46 companies are pure distributors, suppliers or plant manufacturers. 80 of the 126 pharmaceutical companies carry out research, development and/or manufacture in Baden-Württemberg. The Baden-Württemberg Statistics Office has been able to acquire key figures for 2013 for all of the 80 companies:
Around two thirds of revenue (4.49 billion euros) was generated by the 16 companies with more than 250 employees.
The 2014 export rate was 70.2 percent (figures based on companies with more than 20 employees).
In 2014, the companies produced pharmaceutical products worth 3.93 billion euros.
Most pharmaceutical companies are located in the Stuttgart region (15) and in the central and southern Upper Rhine regions (14 each).
Danube-Iller and Rhine-Neckar are the two regions with the highest revenues. Companies in the Danube-Iller region generated 36 % of overall revenues and companies in the Rhine-Neckar region, 18 %.